Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.

Slides:



Advertisements
Similar presentations
1 Community Support to Forest related Research European forest research – outlook for the future Brussels, 12 November 2004 Christian PATERMANN Director.
Advertisements

Science, research and developmentEuropean Commission LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH Applications of knowledge and technologies in.
DG ResearchEuropean Commission 1 DG RTD/E.2/JL - 8/16/2014 Scientific Support to Policies Dr. Hans-Jörg Lutzeyer European Commission Research Directorate-General.
Indridi Benediktsson June 2007 International Collaboration in FP7 Health Research Dr. Indridi Benediktsson Directorate Health Horizontal Aspects and Coordination.
European Framework Programme for Business FP7 UK Technology Strategy Board Driving Innovation FP7UK Opportunities in FP 7 The Health research theme Biomed.
EU support for Health Research: from FP6 to FP7
Research & Innovation Evolution from IMI1 to IMI2: challenges ahead Elmar Nimmesgern, PhD DG Research & Innovation 1.
EU and PL participation in submitted and ranked proposals Sixth Framework Programme UE P1 Life Sciences Results of the first call for proposals.
Sociedade Portuguesa de Inovação Brussels, February 2006 Overview of Recent Collaborative Efforts between the European and the Chinese Research Communities.
Combating major diseases Gender aspects in research Gender aspects in research have a particular relevance to this theme as risk factors, biological mechanisms,
EU Research and Innovation Policy
21 October 2005 CNRS Building the Europe of Knowledge Octavi Quintana Trias, Director, European Commission Health Research Directorate, DG Research, Health.
Main headings  Integrating European Research Priority thematic areas Specific SME activities Specific international cooperation activities JRC activities.
Companies and the Sixth Framework Programme. Agenda Overview of the 6 th Framework Programme (FP6) Why participate ? Industry participation in FP6 What’s.
EoI assesment and presentation NCP 24 October 2002 Confronting the major communicable diseases linked to poverty Health Directorate F3 unit: Poverty related.
Dr Bruno Hansen Director for Life Sciences Dr Bruno Hansen Director for Life Sciences EC - DG Research Electromagnetic fields, mobile telephony and Health.
DG ResearchEuropean Commission 1 FOOD QUALITY AND SAFETY DG RTD/E.2/JL - 8/8/2015 Development of new health-promoting foods Impact of Food on Health Scientific.
Title of Presentation 1 EU-ASEAN S&T cooperation to jointly tackle societal challenges Opportunities for future EU-ASEAN collaborations.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.
Sixth Framework Programme INTRODUCTION . Contents Contents of FP6 Instruments in FP6 Financing Budgets Timetable Highlights.
FP 6- Thematic Priority 4 Aeronautics & Space Joseph Prieur - Aeronautics DG Research- Space &Transport.
Building the Europe of Knowledge for Growth Proposals for the 7 th Research Framework Programme 2007 – 2013 adopted by the Commission on 6 April 2005 Dr.
Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.
Director, DG RTD, Directorate International Cooperation
The Sixth RTD Framework Programme Thematic Priority 1 Life Sciences: Genomics & Biotechnology for Health
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 The Sixth Framework Programme and Policy Support Research – “Priority 8” Parallel.
Dr. José M. Millán, PhD Deputy Director of CIBERER Universitary Hospital La Fe, Valencia, Spain Barriers and Challenges in Rare Diseases Research Centre.
Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,
Precision Medicine A New Initiative. The Concept of Precision Medicine (PM) The prevention and treatment strategies that take individual variability into.
1 EU-funded health research activities against TB: FP6 actions and perspectives toward FP7 DG Research - European Commission 22 MARCH 2007.
Thematic priorities - Dr. Inz Matthijs Soede “Framework Programme 6 To a European Research Area Poznan - 21 November 2002 Dr. Ir. Matthijs Soede Senter/EG-Liaison.
Фондация ГИС Трансфер Център г. Sofia Лектор: Kostadin Kostadiov Проект: EURESP+, ENT/CIP/10/D/
1 The 6 th European Research Framework Program Future & Emerging Technologies 3 rd QIPC call information event: 17 February 2004 Bratislava Dr. Gustav.
Information Society Technologies (IST) Programme 5th EU RTD Framework Programme.
Clinical trials in Framework programme 7 (FP7) EU Judita Kinkorová 2. Národní konference o doporučených postupech, Olomouc 13. listopadu 2010.
Building the Europe of Knowledge Proposals for the 7 th Research Framework Programme
Training courses Presentation by JC Consultants Website :
SUSTAINABLE DEVELOPMENT, GLOBAL CHANGE AND ECOSYSTEMS A Edwards – ADC, Seattle, 2006 Slide 1 European Community RTD Framework Programmes ADC.
1 SMEs – a priority for FP6 Barend Verachtert DG Research Unit B3 - Research and SMEs.
IST4Balt Training Course on FP6 and IST Version 2.0, 30/05/20061 IST4Balt Training Course “The Sixth Framework Programme (FP6) of the European Community.
Seventh Framework Programme Theme 1 - Health Ph D.Olguta Iordache Health - NCP.
1 Dr Alfredo Aguilar Head of Unit Biotechnologies Directorate Food, Agriculture and Biotechnology Directorate-General for Research European Commission.
Agency for International Science and Technology Development Programmes in Lithuania A. Goštauto str , LT Vilnius Phone: (370 5) , Fax:
Poznan 19 April Kwietnia 2005 Poznan FP6 The Next Calls for 2005 Technology Platforms FP7.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
International scientific cooperation in FP6: Future calls for proposals JULY 2004 European Commission, Unit N2 International Scientific Cooperation Projects.
Alun JONES EU Network Manager European Agency for Safety and Health at Work 6 th Framework Programme on Research.
FP7 /1 EUROPEAN COMMISSION - DG Research Building a Europe of Knowledge Towards the SeventhFrameworkProgramme
1 Priority 3 NMP: generalities Renzo TOMELLINI Head of Unit “Nanosciences and Nanotechnologies” Directorate “Industrial Technologies” Research Directorate-general.
“ANTAGONISM”“SYNAGONISM” versus alias Co-operation vs Competition: a universal model Spyros Konidaris European Commission "The views expressed in this.
EHFG 7 October 2005 – Patient Safety & Research UK Presidency Workshop on Patient Safety, EHFG, Bad Hofgastein,7 September 2005 Kevin McCarthy, European.
1 Framework Programme 7 Overview. 2 The Programmes within FP7 IDEAS European Research Counsel ERC PEOPLE Marie Curie Measures Initial Training Life-long.
E u r o p e a n C o m m i s s i o n - W a r s a w 2002 Sixth Framework Programme Instruments.
Materials Research in the 6th Framework Programme Anne de Baas Materials Unit, DG Research, EC Cracow 15Sept 2004.
Practical Aspects of Preparation FP 6 projects Senter/EG-Liaison Nationaal Contact Punt voor het 6de Kaderprogramma Sandra de Wild 11 december 2002.
The 7th Framework Programme for Research: Strategy of international cooperation activities Robert Burmanjer Head of Unit, “International Scientific Cooperation.
Cultural Heritage in Tomorrow ’s Knowledge Society Cultural Heritage in Tomorrow ’s Knowledge Society Claude Poliart Project Officer Cultural Heritage.
Research and Innovation Research and Innovation Research and Innovation Research and Innovation Horizon 2020 The EU Framework Programme for Research and.
National Information Day Greece 23 July 2015 Funding priorities under the work plan 2015.
Richard Escritt, Director – Coordination of Community Actions DG Research, European Commission “The development of the ERA: Experiences from FP6 and reflections.
NETWORKS OF EXCELLENCE KEY ISSUES David Fuegi
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
6th Framework Programme – Research for Policy - November 2002 The Sixth Framework Programme and Policy Support Research – “Priority 8” “Priority 8” - 6th.
The Seventh Framework Programme
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Priority 3 NMP: generalities
The challenge of European Research
6th Framework Programme
6th Framework Programme
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Presentation transcript:

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health Dr Alfredo Aguilar Head of Unit Biotechnology and Applied Genomics Research Directorate General European Commission

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Framework Programme Focussing and Integrating Community Focussing and Integrating Community Research To assemble a critical mass of resources and support integration of EU research capacities in 7 priority areas supporting policies and anticipating needs SME International cooperation JRC (non-nuclear research) Structuring ERA To structure the ERA in: Research & Innovation Training & Mobility Infrastructures Science & Society Strenghtening the ERA Foundations To co-ordinate EU research activities To support the development of research/innovation policies

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September Priority Thematic Areas 1. Life Sciences, Genomics and Biotechnology 2255 for Health 2. Information Society Technologies Nanotechnologies, Multifunctional Materials and New Production Systems and devices Aeronautics and Space Food Quality and Safety Sustainable Development,Global Change and Ecosystems Citizens and Governance in a Knowledge Society 225 Budget proposed (EUR million)

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Framework Programme 6 ( ) Thematic priorities Focus on strategic areas where immediate and longer term integration of European research is needed to generate and sustain necessary critical mass New knowledge >> understanding >>application

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Priority ‘Life Sciences, Genomics and Biotechnology for Health’ To help Europe to exploit breakthroughs in decoding the genomes of living organisms for the benefit of : - public health - citizens - increase the competitiveness of European biotechnology industry

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Priority 1: Life Sciences, Genomics and Biotechnology for Health Advanced genomics and its application for health (1100 Millions Euros): Fundamental knowledge and basic tools for functional genomics in all organisms Applications of knowledge and technologies in the field of genomics and biotechnology for health Combating major diseases (1155 Millions Euros): Application-oriented genomic approaches to medical knowledge and technologies Confronting the major communicable diseases linked to poverty

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Fundamental knowledge and basic tools for functional genomics in all organisms Objective: Understanding of genomic information, by developing the knowledge base, tools and resources needed to decipher the function of genes and gene products. - Research actions: gene expression and proteomics - Structural genomics - Comparative genomics - Comparative genomics and population genetics - Bioinformatics - Multidisciplinary functional genomics approaches to basic biological process APPLICATIONS MedicineAgricultureQuality of LifeEnvironment

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Applications of knowledge and technologies in the field of genomics and biotechnology for health (i) Objective: Foster the competitiveness of Europe’s biotechnology industry by exploiting the wealth of biological data produced by genomics and advances in biotechnology. - Research actions: Technological platforms for the development in the fields of new diagnostics, prevention and therapeutic tools … with an active and early involvement of regulators, experts on ethics, patients and society at large. APPLICATIONS Health Care DiagnosticsCost Reduction Individualised treatment New drugs and therapies

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002  Technological platforms for developments in the field of new diagnostic, prevention and therapeutic tools : Applications of knowledge and technologies in the field of genomics and biotechnology for health (ii) Rational and accelerated development of new, safer, more effective drugs including pharmacogenomics approaches Development of new diagnostics Development of new in vitro tests to replace animal testing Development and testing of new preventive and therapeutic tools (such as somatic gene and cell therapies [stem cells therapies]) Immunotherapies Innovative research in post-genomics, which has high potential for application

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Application-oriented genomic approaches to medical knowledge and technologies Objective: to develop improved strategies for the prevention and management of human disease and for living and ageing healthy. Research actions: - Combating cardiovascular diseases, diabetes and rare diseases - Combating resistance to antibiotics and other drugs - Studying the brain and combating diseases of the nervous system - Studying human development and the ageing process - Combating cancer APPLICATIONS Bringing basic knowledge through to clinical applications Improved patient- oriented strategies

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Confronting the major communicable diseases linked to poverty Objective: To confront the global emergency caused by the three major communicable diseases HIV/AIDS, malaria and tuberculosis through the development of effective disease interventions, particularly for use in developing countries.

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Ongoing and coming trends... 7 June 2002 deadline for the “Invitation to submit Expressions of Interest”. November 2002, First Call for Proposals, Framework Programme 6 To keep you informed with the latest news… … and with the new instruments, rules for participation,… Help and information : for Priority “Life Sciences, Genomics and Biotechnology for Health”: Opportunities for Life Sciences, Genomics and Biotechnology for Health in Framework Programme 6 ( )